XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Interim Statements of Operations (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Operating expenses        
Research and development $ 5,020 $ 2,914 $ 11,907 $ 5,659
General and administrative 3,175 3,340 5,337 5,915
Total operating expenses 8,195 6,254 17,244 11,574
Financing expense (income), net (259) 480 (576) 264
Loss before taxes 7,936 6,734 16,668 11,838
Taxes on income (benefit) 34 (544) 55 (544)
Net loss for the period $ 7,970 $ 6,190 $ 16,723 $ 11,294
Basic loss per Ordinary Share [1] $ 0.036 $ 0.027 $ 0.076 $ 0.05
Diluted loss per Ordinary Share $ 0.036 $ 0.027 $ 0.076 $ 0.05
Weighted average number of Ordinary Shares outstanding, basic [1] 221,674,130 228,173,276 221,338,951 228,132,249
Weighted average number of Ordinary Shares outstanding, diluted 221,674,130 228,173,276 221,338,951 228,132,249
[1] 1 American Depositary Share (ADS) represents 20 Ordinary Shares